Waters Q2 revenue rises to $1.645 billion, GAAP loss $1.39 a share; guidance raised
Waters reported second-quarter 2026 results on August 4, 2026, with reported revenue of $1.645 billion, up from $771 million a year earlier. The acquired Biosciences and Diagnostic Solutions businesses contributed $817 million of that revenue. The company posted a GAAP net loss of $136 million, or $1.39 per diluted share, reflecting acquisition-related purchase accounting charges, while adjusted EPS rose 3% to $3.05 and Waters raised all components of its full-year 2026 guidance.
Key points
- Organic revenue of $828 million grew 7% as reported and 9% in constant currency.
- GAAP diluted loss of $1.39 per share, compared with diluted EPS of $2.47 in the second quarter of 2025.
- Adjusted EPS of $3.05, compared with $2.95 a year earlier.
- Full-year 2026 adjusted EPS guidance raised to $14.45 to $14.65; total reported revenue expected at $6.415 billion to $6.476 billion.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:30 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 04, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.